BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6743337)

  • 1. Tiazofurin-induced selective depression of NAD content in hepatoma 3924A.
    Liepnieks JJ; Faderan MA; Lui MS; Weber G
    Biochem Biophys Res Commun; 1984 Jul; 122(1):345-9. PubMed ID: 6743337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targets and markers of selective action of tiazofurin.
    Weber G; Natsumeda Y; Pillwein K
    Adv Enzyme Regul; 1985; 24():45-65. PubMed ID: 2424286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide).
    Lui MS; Faderan MA; Liepnieks JJ; Natsumeda Y; Olah E; Jayaram HN; Weber G
    J Biol Chem; 1984 Apr; 259(8):5078-82. PubMed ID: 6143752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
    Weber G; Natsumeda Y; Lui MS; Faderan MA; Liepnieks JJ; Elliott WL
    Adv Enzyme Regul; 1984; 22():69-93. PubMed ID: 6206692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical mechanisms of resistance to tiazofurin.
    Jayaram HN
    Adv Enzyme Regul; 1985; 24():67-89. PubMed ID: 3835825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of resistance to tiazofurin in hepatoma 3924A.
    Jayaram HN; Pillwein K; Lui MS; Faderan MA; Weber G
    Biochem Pharmacol; 1986 Feb; 35(4):587-93. PubMed ID: 2868729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schedule-dependent synergistic action of tiazofurin and dipyridamole on hepatoma 3924A cells.
    Jayaram HN; Murayama K; Pillwein K; Zhen W; Weber G
    Cancer Chemother Pharmacol; 1992; 31(2):93-6. PubMed ID: 1451238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic cytotoxic effect of tiazofurin and ribavirin in hepatoma cells.
    Natsumeda Y; Yamada Y; Yamaji Y; Weber G
    Biochem Biophys Res Commun; 1988 May; 153(1):321-7. PubMed ID: 2897852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of antimetabolite action by dibromodulcitol in cell culture.
    Oláh E; Kremmer T; Boldizsár M
    Adv Enzyme Regul; 1985; 24():155-75. PubMed ID: 3835819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of purine and pyrimidine metabolism by insulin and by resistance to tiazofurin.
    Weber G; Lui MS; Jayaram HN; Pillwein K; Natsumeda Y; Faderan MA; Reardon MA
    Adv Enzyme Regul; 1985; 23():81-99. PubMed ID: 3907307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of nicotinamide adenine dinucleotide and poly(adenosine diphosphoribose) metabolism by the synthetic "C" nucleoside analogs, tiazofurin and selenazofurin. A new strategy for cancer chemotherapy.
    Berger NA; Berger SJ; Catino DM; Petzold SJ; Robins RK
    J Clin Invest; 1985 Feb; 75(2):702-9. PubMed ID: 3919063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase.
    Yamada Y; Natsumeda Y; Weber G
    Biochemistry; 1988 Mar; 27(6):2193-6. PubMed ID: 2897864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells.
    Olah E; Kote Z; Natsumeda Y; Yamaji Y; Jarai G; Lapis E; Financsek I; Weber G
    Cancer Biochem Biophys; 1990 Apr; 11(2):107-17. PubMed ID: 1974479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurin.
    Weber G; Yamaji Y; Olah E; Natsumeda Y; Jayaram HN; Lapis E; Zhen WN; Prajda N; Hoffman R; Tricot GJ
    Adv Enzyme Regul; 1989; 28():335-56. PubMed ID: 2576178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia.
    Weber G; Jayaram HN; Lapis E; Natsumeda Y; Yamada Y; Yamaji Y; Tricot GJ; Hoffman R
    Adv Enzyme Regul; 1988; 27():405-33. PubMed ID: 2907968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and antitumor activity of tiazofurin and its selenium analog (2-beta-D-ribofuranosyl-4-selenazolecarboxamide).
    Boritzki TJ; Berry DA; Besserer JA; Cook PD; Fry DW; Leopold WR; Jackson RC
    Biochem Pharmacol; 1985 Apr; 34(7):1109-14. PubMed ID: 3985993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow.
    Prajda N; Hata Y; Abonyi M; Singhal RL; Weber G
    Cancer Res; 1993 Dec; 53(24):5982-6. PubMed ID: 7903199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic action of taxol and tiazofurin in human ovarian, pancreatic and lung carcinoma cells.
    Taniki T; Prajda N; Monden Y; Weber G
    Cancer Biochem Biophys; 1993 Sep; 13(4):295-302. PubMed ID: 8521379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of the activities of IMP dehydrogenase and GMP synthase after treatment with tiazofurin and acivicin in hepatoma cells in vitro.
    Ikegami T; Natsumeda Y; Weber G
    Adv Exp Med Biol; 1989; 253B():299-304. PubMed ID: 2575350
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of purine and tiazofurin metabolism in drug sensitive human chronic myelogenous leukemia K 562 cells.
    Pillwein K; Jayaram HN; Weber G
    Blut; 1988 Aug; 57(2):97-100. PubMed ID: 3165681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.